跳至主要内容
临床试验/CTRI/2012/05/002687
CTRI/2012/05/002687已完成3 期

An Investigation of the Effect of Long-Term Electrical Stimulation on Lower Esophageal Sphincter (LES) Pressure and Esophageal Acid Exposure in Patients with Gastroesophageal Reflux Disease (GERD) - NA

Endostim Inc0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
Endostim Inc
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Subject is between 21 â?? 70 years of age.
  • -Subject has a history of heartburn, regurgitation or both for >12 month prompting physician recommendation of continual daily use of PPI before study entry.
  • -Baseline GERD HRQL heartburn score >= 20 following 10-14 days off PPI and at least 10 points higher than the On PPI score
  • -Subject who are on standard medical therapy for 12 months or longer and experience discomfort or who are otherwise dissatisfied with GERD symptoms
  • -Subjects with a GERD condition that in the opinion of the PI justifies a minimally invasive reversible procedure prior to attempting anatomical change such as Nissen Fundoplication
  • -Subject has an American Society of Anesthesiologists (ASA) Physical Status Classification I or II (or comparable local classification if any).
  • -Subject has exhibited excessive lower esophageal acid exposure during 24-hour pH-metry of antisecretory therapy performed within 6 months of screening visit; pH < 4 for > 5% of total time.
  • -Subject has a resting LES end expiratory pressure >= 5mm Hg and <= 15 mmHg on a high resolution manometry within 6 months of enrollment.
  • -Subject has esophagitis <= Grade C (LA classification) on upper endoscopy within 6 months of enrollment.
  • -Subject has esophageal body contraction amplitude > 30 mmHg for >50% of swallows and > 50% peristaltic contractions on high resolution manometry.
  • -Subject has signed the informed consent form and is able to adhere to study visit schedule.

排除标准

  • -Subject has any non-GERD esophageal motility disorders.
  • -Subject has gastroparesis.
  • -Subject has any significant multisystem diseases.
  • -Subject has an autoimmune or a connective tissue disorder (e.g. scleroderma, dematomyositis, Calcinosis-Raynaudâ??s-Esophagus Sclerodactyly Syndrome (CREST), Sjogrenâ??s Syndrome, Sharpâ??s Syndrome) requiring therapy in the preceding 2 years.
  • -Subject has Barrettâ??s epithelium ( M2; C1) or any grade of dysplasia.
  • -Subject has a hiatal hernia larger than 3 cm.
  • -Subject has a body mass index (BMI) greater than 35 kg/m2.
  • -Subject has Type 1 diabetes mellitus
  • -Subject has uncontrolled Type 2 diabetes mellitus (T2DM) defined as HbA1c 9.5 in the previous 6 months, or has T2DM for 10 years.
  • -Subject has a history of suspected or confirmed esophageal or gastric cancer.
  • -Subject has esophageal or gastric varices.
  • -Subject has significant cardiac arrhythmia or ectopy or significant cardiovascular disease.
  • -Subject has an existing implanted electrical stimulator (e.g., pacemaker, AICD).
  • -Subject requires chronic anticoagulant therapy.
  • -Subject has dysphagia or esophageal peptic stricture, excluding Schatzkiâ??s ring.
  • -Subject of child-bearing potential who is pregnant or intends to become pregnant during the trial period.
  • -Subject is currently enrolled in other potentially confounding research.
  • -History of any malignancy in the last 2 years.
  • -History of previous esophageal or gastric surgery, including nissen fundoplication.
  • -Subject has any condition that, at the discretion of the investigator or sponsor, would preclude participation in the trial.

研究者

发起方
Endostim Inc

相似试验

Effect of Long-Term Electrical Stimulation on LES... | 临床试验